Abstract
Potent antiresorptive agents have been developed for the treatment of osteoporosis and bone disorders. There are few agents available that stimulate bone formation. Recently, treatment with parathyroid hormone was found to induce a potent increase in hip and lumbar bone mineral density (BMD). The present review focus on growth hormone (GH) / growth hormone secretagogues (GHSs). GH / GHSs stimulates bone turnover, thereby increasing bone mass and density.
Keywords: Growth hormone, secretagogue, bone mineral content, bone mineral density
Current Pharmaceutical Design
Title: The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density
Volume: 8 Issue: 23
Author(s): Johan Svensson
Affiliation:
Keywords: Growth hormone, secretagogue, bone mineral content, bone mineral density
Abstract: Potent antiresorptive agents have been developed for the treatment of osteoporosis and bone disorders. There are few agents available that stimulate bone formation. Recently, treatment with parathyroid hormone was found to induce a potent increase in hip and lumbar bone mineral density (BMD). The present review focus on growth hormone (GH) / growth hormone secretagogues (GHSs). GH / GHSs stimulates bone turnover, thereby increasing bone mass and density.
Export Options
About this article
Cite this article as:
Svensson Johan, The Importance of Growth Hormone (GH) and GH Secretagogues for Bone Mass and Density, Current Pharmaceutical Design 2002; 8 (23) . https://dx.doi.org/10.2174/1381612023393413
DOI https://dx.doi.org/10.2174/1381612023393413 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target
Current Pharmaceutical Design Nanoparticles for Tumor Targeted Therapies and Their Pharmacokinetics
Current Drug Metabolism How and Why to Screen for CYP2D6 Interindividual Variability in Patients Under Pharmacological Treatments
Current Drug Metabolism Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Leptin and Inflammation
Current Immunology Reviews (Discontinued) Melatonin and Aromatase in Breast Cancer
Clinical Cancer Drugs The CXCL12/CXCR4 Axis as a Therapeutic Target in Cancer and HIV-1 Infection
Current Medicinal Chemistry Imaging in the Age of Molecular Medicine: Monitoring of Anti-Angiogenic Treatments
Current Pharmaceutical Biotechnology Selectively Replicating Adenoviruses for Oncolytic Therapy
Current Cancer Drug Targets Review: Alternative Splicing (AS) of Genes As An Approach for Generating Protein Complexity
Current Genomics SNP Analysis Combined with Protein Structure Prediction Defines Structure- Functional Relationships in Cancer Related Cytochrome P450 Estrogen Metabolism
Current Medicinal Chemistry Renaissance of the Biologically Active Vitamin A Derivatives: Established and Novel Directed Therapies for Cancer and Chemoprevention
Current Pharmaceutical Design The Role of Mass Spectrometry in the “Omics” Era
Current Organic Chemistry Alkaloids and Flavonoids as α1-Adrenergic Receptor Antagonists
Current Medicinal Chemistry MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Glutamate Carboxypeptidase II: An Overview of Structural Studies and Their Importance for Structure-Based Drug Design and Deciphering the Reaction Mechanism of the Enzyme
Current Medicinal Chemistry Antiangiogenic Therapy
Current Pharmaceutical Design Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs
Current Drug Targets Metabolic and Amino Acid Alterations of the Tumor Microenvironment
Current Medicinal Chemistry